NRC issued the final Safety Evaluation Report and Environmental Impact Statement in relation to the proposed uranium enrichment facility planned by Global Laser Enrichment. Mandatory hearings in relation to the licence application were held in July and in September the NRC issued its decision in relation to the application. NRC approves GLE’s licence application to construct and operate a commercial uranium enrichment plant utilising the SILEX Technology.
Solar Systems was awarded a funding grant from the Australian Solar Institute. The business also secured two sites for demonstration facilities in Beaumont, California (USA) and at Nofa Equestrian Resort in Saudi Arabia. Solar Systems opened its Test & Demonstration Facility at Bridgewater in Victoria.
Following a significant business restructure and continuing challenging trading conditions in the Australian solar panel market, Silex decided to cease the panel manufacturing operations at Silex Solar’s Sydney Olympic Park plant.
Silex Systems’ head office relocated to Sydney CBD in September.
Silex successfully completed a capital raising of $89 million and a share purchase plan which raised a further $20 million (total capital raised of $109 million).
Completion of a $75 million Federal Government funding package for the 100MW Mildura solar power station was announced by Solar Systems in June. A $50 million package from the Victorian Government for the same project was confirmed in 2010.
GLE and Silex announced the successful completion of the Test Loop initial measurement program in April.
Silex acquired the business assets of Melbourne based Solar Systems in March for $20 million. Solar Systems’ concentrating PV technology is applicable to large utility-scale solar power generation, using its unique ultra-high efficiency ‘Dense Array’ technology.
In June, Silex announced the acquisition of the Sydney Olympic Park (SOP) solar photovoltaic (PV) panel manufacturing facility - the only PV panel plant in Australia.
GLE submitted a licence application to the US NRC to build and operate a commercial SILEX uranium-enrichment facility in Wilmington. In August, the NRC announced it had accepted the licence application, triggering a ~30 month review process.
In July, GLE announced the on-schedule start-up of the Test Loop to evaluate the next-generation SILEX uranium enrichment technology.
Global Laser Enrichment (GLE), formed as a subsidiary of GE Hitachi Nuclear Energy (GEH) to commercialise the SILEX Technology, announced that it had selected its Wilmington, North Carolina headquarters site for the first potential commercial SILEX uranium enrichment facility.
GLE was notified that the U.S. Nuclear Regulatory Commission (NRC) approved a license to operate the test Loop for the next generation SILEX laser enrichment technology.
GEH and Cameco Corp. announced that Cameco Corporation, the world’s largest uranium producer, had joined the GLE venture.
Cameco paid US$123.8 million for a 24% stake in GLE. GE retained 51% ownership with Hitachi at 25%.
Transfer of the SILEX Uranium Enrichment project to GE’s Wilmington, North Carolina (USA) nuclear fuel plant was completed in the first half of 2007. Hitachi joined GE as project partner.
GE-Hitachi signs Letters of Intent for uranium enrichment services and support using the SILEX Technology with Exelon and Entergy - the two largest nuclear power utilities in the USA.
Silex successfully completes a $50 million capital raising in October.
Silex and the General Electric Company sign an exclusive Commercialisation and License Agreement for the SILEX Uranium Enrichment Technology in May, with US Government authorisations received in October.
Translucent wins a US Defence Department DARPA Grant to help develop the ‘optical silicon’ technology, under DARPA’s Electronics and Photonics Integrated Circuits (EPIC) Program.
Subsidiary ChronoLogic wins a Federal Government “Commercial Ready Grant” for its novel ‘USB-inSyncTM’ Data Acquisition technology ($1.2 million for three years).
Silex commissioned the world’s first silicon laser enrichment pilot plant.
Translucent secured its first US Patent for ‘optical silicon’ and filed patents for Silicon-on-Insulator (SOI) and dielectric substrates for the silicon chip industry.
Silex took a majority ownership in Translucent Inc, moving to ~70% interest (from 30%). Silex also increased its stake in ChronoLogic to 90%.
Silex acquired a controlling 51% interest in ChronoLogic Pty Ltd, Adelaide-based start-up developing novel technology for the electronics and instrumentation industries.
The SILEX Uranium Enrichment Project achieved a key milestone with the first full demonstration on practical uranium enrichment using the SILEX ‘Direct Measurement Facility’.
Silex entered the semiconductor materials field with the acquisition of a 30% interest in Translucent Inc, a Silicon Valley start-up developing silicon photonics technology.
The SILEX Technology was officially “Classified” by the US and Australian Governments. The implications of classification relate mainly to security protocols.
The first macroscopic demonstration of the SILEX uranium process was successfully achieved.
Silex won the 2000 Australian Technology Award for Excellence in the Manufacturing and Engineering sector.
Silex raised $36 million through a share issue to assist in funding the development of the Company’s technology portfolio.
An Agreement for Cooperation between the United States and Australian Governments was signed paving the way for continued development of the SILEX Technology for uranium enrichment, and facilitating its future transfer to the US.
Silex listed on the Australian Stock Exchange on 8 May 1998.
Silex was divested from Sonic and set about establishing the commercial viability of the SILEX technology.
‘Proof of Principle’ demonstration of the SILEX Process was achieved at the Company’s laboratories in Lucas Heights, south of Sydney. Uranium Enrichment, the largest market for isotope separation, became the primary focus of the Company.
The unique principles of the SILEX (Separation of Isotopes by Laser EXcitation) Process were formulated.
Silex began researching the isotope separation ideas of the co-inventors Dr Michael Goldsworthy and Dr Horst Struve.
Silex was established by founder Dr. Michael Goldsworthy as a technology research and development subsidiary of Sonic Healthcare Limited, an Australian publicly listed company.